Sawhney, R;
Jalan, R;
(2015)
Liver: the gut is a key target of therapy in hepatic encephalopathy.
Nature Reviews Gastroenterology & Hepatology
, 12
(1)
pp. 7-8.
10.1038/nrgastro.2014.185.
Preview |
Text
Nat Rev Gastro Hep PEG vs Lactulose commentary FINAL.pdf Download (89kB) | Preview |
Abstract
Little progress has been made in the pharmacological management of patients with hepatic encephalopathy, partly because it is difficult to perform clinical trials in this group of patients. A new clinical trial now suggests that polyethylene glycol is more effective than the current standard first-line therapy in these patients.
| Type: | Article |
|---|---|
| Title: | Liver: the gut is a key target of therapy in hepatic encephalopathy. |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/nrgastro.2014.185 |
| Publisher version: | http://dx.doi.org/10.1038/nrgastro.2014.185 |
| Language: | English |
| Keywords: | Gastrointestinal Agents, Hepatic Encephalopathy, Humans, Intestines, Lactulose, Polyethylene Glycols, Rifamycins, Treatment Outcome |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1470326 |
Archive Staff Only
 |
View Item |
